Episode Details

In this episode of TDR Cannabis in Five, host Shadd Dales covers one of the biggest federal cannabis documents ever released: the 252-page report from HHS, originally submitted to the DEA in August 2023. The report recommended moving cannabis from Schedule I to Schedule III — and laid out detailed scientific evidence showing medical use, lower abuse potential, and clear public-health benefits compared to strict prohibition.Shadd breaks down what the report actually found: clinical evidence supporting medical use, the FDA’s eight-factor analysis, the risks and benefits the government acknowledged, and the economic and regulatory consequences rescheduling would trigger. The discussion cuts through noise and focuses on what the federal government put in writing — not speculation.The episode also touches on how the report could shape research access, banking, tax rules, pharmaceutical engagement, and long-term investor confidence. While rescheduling isn’t legalization, the shift away from “no medical use” is a major narrative pivot.The conclusion stays grounded: the report doesn’t guarantee anything, and DEA still holds the final decision. But the detail, tone, and scientific backing make it a foundational moment in modern cannabis policy. It’s worth understanding for anyone who follows the sector seriously.#HHSReport #CannabisRescheduling #ScheduleIII #CannabisScience #TDRCannabisInFive #ShaddDales #CannabisPolicy #CannabisResearch #MorganAndMorgan #CannabisIndustryWant to see more Cannabis Reform videos?   • Three Months That Made Cannabis Impossible...     • Three Months That Made Cannabis Impossible...     • High Tide Executive Warns the Canadian Can...     • Texas Moves Ahead Despite the Federal Ban ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / theda